The Effects of Different Forms of Contraceptives on the Coagulation Profile
A prospective case- control study
DOI:
https://doi.org/10.37506/5evcbf35Keywords:
venous thromboembolism,, oral contraceptives, coagulation, birth control, thrombosis riskAbstract
Background: The association between combined oral contraceptive pills and increased risk of venous thromboembolism has been extensively researched but little has been reported on its effects on all haematological parameters and coagulation factors. This study aimed to evaluate the effects of different forms of oral contraceptives on the coagulation profile of female subjects in Enugu metropolis. This case-control study was conducted among women attending the Family planning unit of University of Nigera Teaching Hospital, Ituku Ozalla, Enugu State.
Methods: The subjects were 36 women undergoing oral contraceptive medication and the control were 36 healthy women not taking this medication. ABO blood grouping and Full blood count (FBC) were carried out while prothrombin time (PT) and activated partial thromboplastin time (APTT) of test subjects were determined using test kits from Technoclone Austria. Most of the test subjects were found to be of the O + blood group. The haematological profile of test subjects showed a statistically significant increase in Red blood cell (RBC), packed cell volume (PCV), neutrophil, eosinophil, mean platelet volume (MPV) and plateletcrit while showing statistically
significant reductions in mean cell volume (MCV), mean cell haemoglobin (MCH), mean cell haemoglobin concentration (MCHC), lymphocyte, basophil, platelet volume distribution width (PDW) and red cell distribution widths in comparison to the control group. There was a significant decrease in the PT of test subjects (16.06±1.35 secs) in comparison to the control group (19.63±1.28 secs) while the slight increase in their APTT values was not significant.
Conclusion: Thrombotic markers such as increased Red cell markers; RBC, haematocrit and platelet indices; MPV, PCT were increased along with decreased PT levels and prolonged APTT values though not significant can link oral contraceptives medication use to a hypercoagulable state in subjects thereby increasing their risk to venous thromboembolism.
References
Stocco B, Fumagalli HF, Franceschini SA, Martinez EZ, Marzocchi-Machado CM, de Sa MF, Toloi MR. Comparative study of the effects of combined oral contraceptives in hemostatic variables: an observational preliminary study. Medicine. 2015 Jan 1;94(4):e385.
Paoletti R, Crosignani PG, Kenemans P, Samsioe G, Soma MR. Connective Tissue Changes. Women’s Health and Menopause: Risk Reduction Strategies. 2012 Dec 6;11:1623.
Lancé MD. A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thrombosis journal. 2015 Dec;13:1-6.
McFarlane DR, Grossman R. Contraceptive History and Practice. Global Population and Reproductive Health. 2014 Jul 18:143.
Christin-Maitre S. History of oral contraceptive drugs and their use worldwide. Best practice & research Clinical endocrinology & metabolism. 2013 Feb 1;27(1):3-12.
Cooper DB, Patel P, Mahdy H. Oral contraceptive pills.
Grimes DA, Schulz KF. Nonspecific side effects of oral contraceptives: nocebo or noise? Contraception. 2011 Jan 1;83(1):5-9.
Lindh I, Hognert H, Milsom I. The changing pattern of contraceptive use and pregnancies in four generations of young women. Acta obstetricia et gynecologica Scandinavica. 2016 Nov;95(11):1264-72.
Poromaa IS, Segebladh B. Adverse mood symptoms with oral contraceptives. Acta obstetricia et gynecologica Scandinavica. 2012 Apr;91(4):420-7.9
Golobof A, Kiley J. The current status of oral contraceptives: progress and recent innovations. InSeminars in reproductive medicine 2016 May (Vol. 34, No. 03, pp. 145-151).Thieme Medical Publishers.
Gialeraki A, Valsami S, Pittaras T, Panayiotakopoulos G, Politou M. Oral contraceptives and HRT risk of thrombosis. Clinical and Applied Thrombosis/Hemostasis. 2018 Mar;24(2):217-25.
Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database of Systematic Reviews. 2014(1).
Kharbanda EO, Parker ED, Sinaiko AR, Daley MF, Margolis KL, Becker M, Sherwood NE, Magid DJ, O’Connor PJ. Initiation of oral contraceptives and changes in blood pressure and body mass index in healthy adolescents. The Journal of pediatrics. 2014 Nov 1;165(5):1029-33.
Kaminski P, Szpotanska-Sikorska M, Wielgos M. Cardiovascular risk and the use of oral contraceptives. Neuroendocrinology letters. 2013 Jan 1;34:101-5.
Suchon P, Al Frouh F, Henneuse A, Ibrahim M, Brunet D, Barthet MC, Aillaud MF, Venton G, Alessi MC, Trégouët DA, Morange PE. Risk factors for venous thromboembolism in women under combined oral contraceptive. Thrombosis and haemostasis. 2016;115(01):135-42.
Eledo BO, Allagoa DO, Ihedioha AU, Dunga KC, Izah SC. Evaluation of some haematological parameters among post-menopausal women in Bayelsa state, Nigeria: a case study of patients attending Federal Medical Centre, Yenagoa. American Journal of Laboratory Medicine. 2017 Nov;2(6):132-6.
Byrnes JR, Wolberg AS. Red blood cells in thrombosis. Blood, The Journal of the American Society of Hematology. 2017 Oct 19;130(16):1795-9.
Jamil S, Khan RA, Dilshad H, Fatima S. Haematologic variations associated with the long term use of contraceptives in young females. International Journal of Medical Research and Review. 2014;2:580-6.
Swanepoel AC, Emmerson O, Pretorius E. Effect of progesterone and synthetic progestins on whole blood clot formation and erythrocyte structure. Microscopy and Microanalysis. 2017 Jun 1;23(3):607-17.
Chandrashekar, V. (2013). Plateletcrit as a screening tool for detection of platelet quantitative disorders. Journal of Hematology, 2(1), 22-26.
Samsunnahar AQ, Atiquzzaman N, Begum US, Rahman F. Assessment of coagulation disorder in women taking oral contraceptives. Bangladesh Soc Physiol. 2014;9(1).
Chin-Quee D, L'engle K, Otterness C, Mercer S, Chen M. Repeat use of emergency contraceptive pills in urban Kenya and Nigeria. International perspectives on sexual and reproductive health. 2014 Sep 1;40(3):127-34.
Eko Jimmy E, Kalu O, Osuchukwu Nelson C. Prevalence of contraceptive use among women of reproductive age in Calabar Metropolis, Southern Nigeria. Int J Humanit Soc Sci Invent. 2013;2:27-34.
Ujuju C, Adebayo SB, Anyanti J, Oluigbo O, Muhammad F, Ankomah A. An assessment of the quality of advice provided by patent medicine vendors to users of oral contraceptive pills in urban Nigeria. Journal of multidisciplinary healthcare. 2014 Apr 8:163-71.
Hannaford PC, Iversen L, Macfarlane TV, Elliott AM, Angus V, Lee AJ. Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study. Bmj. 2010 Mar 12;340.
Dinger J, Do Minh T, Buttmann N, Bardenheuer K. Effectiveness of oral contraceptive pills in a large US cohort comparing progestogen and regimen. Obstetrics & Gynecology. 2011 Jan 1;117(1):33-40.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Nnadi Ogechukwu Frances, Dr. Eyiuche Doris Ezigbo, Chijioke Noris Ezinwa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.